Data collected will include the number of hospitalizations, reason for hospitalization, whether the hospitalization was for medical or surgical condition, and the length of hospital stay.
Data collected will include the number of sessions completed; mean time spent on the program, average number of sessions per user, and average length of a session.
Data collected will include the number of times a participant accesses the web-based intervention, and the type of information accessed will be recorded by the website.
Intervention data collected will include the length and type of intervention received (for example, back school program, gym program, diabetes education, or the professional seen).
Data collected will include the number of QuitCoach assessments completed and partially completed, number of log-ins to the site, number of openings of the advice page, To Do List and Problem Planner, number of edits of the To Do List, and number of times the additional resources page is viewed.
The information collected will include whether the child's symptoms have resolved, antibiotic consumption, any further contact with health professionals, quality of life data, relevant out-of-pocket expenditure and associated time off work.
Details to be collected will include: Characteristics of the decision problem, such as disease/condition, gene(s), setting, perspective, purpose of the test (eg, to predict a treatment response, aid dose setting, predict adverse drug reactions), type of test (eg, fluorescence in situ hybridisation testing, Sanger sequencing, microarray testing, whole genome sequencing).
The relevant data collected will include ethnicity, education status, hand dominance, co morbidities, smoking, patient contact details, GP name and surgery.
Data collected will include information on socio-demographic characteristics of the health care professionals, training and experience in HIV care, working conditions, practices and knowledge about HIV and ART management, opinions about the UTT strategy.
Data elements collected will include clinical measures including peak flows, asthma medications utilization, and the Asthma Action Plan.
Information collected will include trial characteristics (year of publication, country of origin of the study, methodological quality items of the study), patients' characteristics (number of participants, age, gender), intervention characteristics, comparator characteristics, type of outcome and outcome measures.
